缓冲膨胀局部麻醉在浅静脉功能不全腔内热消融中的随机临床试验
这项随机对照试验将接受大隐静脉腔内热消融联合静脉切除术的患者分配至标准或缓冲膨胀局部麻醉组,主要终点为术中疼痛VAS评分。结果显示缓冲组术中疼痛显著更低(2.86±3.57 vs 4.44±2.94,p=.001),第1周SF-36躯体疼痛评分更优,余结局相当,作者建议缓冲配方替代现有配方。
要点
- 缓冲膨胀局部麻醉可显著降低EVTA术中疼痛VAS评分。
- 第1周SF-36躯体疼痛评分缓冲组更优,余QoL结局相似。
- 技术成功率高,两组均无严重并发症,轻微并发症少。
核心结论
- 缓冲膨胀局部麻醉为EVTA患者提供显著更低的术中疼痛体验,应替代现行膨胀配方。
主要发现
- 术中疼痛VAS评分缓冲组显著更低,均值±SD为2.86±3.57 vs 4.44±2.94(p=.001)。
- 术后1周疼痛评分及镇痛药使用两组相当。
- 第1周SF-36躯体疼痛域评分缓冲组显著更优(77 vs 62;p=.008)。
- AVVQ、SF-36及EQ-5D其余评分随访期间两组相似,均较基线显著改善。
- 两组技术成功率均高,无严重并发症,轻微并发症少。
关键数值与推荐
- 主要终点为患者报告的术中疼痛,采用100 mm视觉模拟量表(VAS)评估。
- 次要终点包括术后1周疼痛VAS及镇痛药使用、QoL(AVVQ、SF-36、EQ-5D)、患者满意度VAS、DUS技术成功及并发症。
临床怎么用
- 在EVTA术中可考虑使用缓冲至生理pH的膨胀局部麻醉以减轻患者术中疼痛。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: Endovenous thermal ablation (EVTA) is the recommended first line intervention for superficial venous incompetence (SVI). While the infiltration of perivenous tumescent local anaesthesia (TLA) is key to procedural success, it is paradoxically the predominant source of patient reported discomfort. This randomised controlled trial investigates the potential to reduce peri-procedural pain and improve patient reported outcome measures (PROMs), including quality of life (QoL) using TLA buffered to physiological pH. METHODS: Patients undergoing great saphenous vein EVTA with concomitant phlebectomies were randomised to either standard (ST) or buffered (BT) TLA. Follow up assessments were performed at weeks 1, 6, and 12. The primary outcome was patient reported peri-procedural pain on a 100 mm visual analogue scale (VAS). Secondary outcomes were one week post-procedural pain VAS and analgesia use, QoL (disease specific: Aberdeen Varicose Vein Questionnaire [AVVQ]; generic: Short Form-36 [SF-36] and EuroQol 5 Dimensions Questionnaire [EQ-5D]), patient satisfaction VAS, technical success on duplex ultrasound (DUS) examination, and complications. RESULTS: Ninety-seven patients were randomised: 50 to ST and 47 to BT. The groups had comparable baseline demographics, Clinical Etiologic Anatomic Pathological, Venous Clinical Severity Score, QoL, and DUS parameters. Equally, intra-procedural parameters (volume of TLA, length of ablation, and linear energy delivered) were also comparable. Peri-procedural pain scores were significantly lower in the BT group with a mean ± SD score of 2.86 ± 3.57 versus 4.44 ± 2.94 (p = .001). Pain scores and analgesia use over the subsequent week were equivalent. SF-36 Bodily Pain domain scores were significantly better in the BT group at week 1 (77 vs. 62; p = .008). AVVQ, SF-36, and EQ-5D scores were otherwise similar between the groups throughout follow up, significantly improving over baseline. Technical success was high in both groups, with no major complications and few minor complications. CONCLUSION: Buffered TLA offers a significantly lower peri-procedural pain experience for patients undergoing EVTA and should replace current tumescent formulae.
引用
- Nandhra S, Wallace T, El-Sheikha J, et al. A Randomised Clinical Trial of Buffered Tumescent Local Anaesthesia During Endothermal Ablation for Superficial Venous Incompetence. Eur J Vasc Endovasc Surg. 2018. PMID: 30392525. doi:10.1016/j.ejvs.2018.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。